Insmed Incorporated
Common Stock · NASDAQ
Live TMS charts are coming soon.
Paper trading. Simulated, no real money.
No public theses on INSM yet. When TMS traders open paper trades on it and make their thesis public, the long and short split, average conviction and hit rate show here.
Key stats load once market data is connected.
Bloomberg News reports that Sanofi is weighing a takeover of Insmed, a US drugmaker. The report is not confirmed by either company, and holders of Insmed would be affected if a deal moves forward.
Unverified rumor. Not financial advice.
Insmed shares rose after a report that Sanofi may be interested in acquiring the company. The headline alone gives no details, and neither company has confirmed any takeover talks.
Unverified rumor. Not financial advice.
Insmed shares rose more than 6% after a report that Sanofi is weighing an acquisition of the company. The report is unconfirmed, and no details on terms or timing were given in the headline.
Unverified rumor. Not financial advice.
No SEC financials for INSM yet. Companies that file 10-K and 10-Q reports show revenue, earnings, cash flow and the balance sheet here.
Source: SEC filings (10-K, 10-Q).
Paper trading only. Nothing here is financial advice.